MILTON FINEGOLD to Treatment Outcome
This is a "connection" page, showing publications MILTON FINEGOLD has written about Treatment Outcome.
Connection Strength
0.133
-
Recurrent nested stromal epithelial tumor of the liver with extrahepatic metastasis: case report and review of literature. Pediatr Dev Pathol. 2008 Nov-Dec; 11(6):469-73.
Score: 0.018
-
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30365.
Score: 0.013
-
Outcomes of children with well-differentiated fetal hepatoblastoma treated with surgery only: Report from Children's Oncology Group Trial, AHEP0731. J Pediatr Surg. 2022 Oct; 57(10):251-256.
Score: 0.012
-
Small cell undifferentiated histology in hepatoblastoma may be unfavorable. Cancer. 2001 Dec 15; 92(12):3130-4.
Score: 0.012
-
Doxorubicin in combination with cisplatin, 5-flourouracil, and vincristine is feasible and effective in unresectable hepatoblastoma: A Children's Oncology Group study. Cancer. 2022 03 01; 128(5):1057-1065.
Score: 0.012
-
Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience. J Pediatr Gastroenterol Nutr. 2019 05; 68(5):695-699.
Score: 0.010
-
Inflammation, Active Fibroplasia, and End-stage Fibrosis in 172 Biliary Atresia Remnants Correlate Poorly With Age at Kasai Portoenterostomy, Visceral Heterotaxy, and Outcome. Am J Surg Pathol. 2018 12; 42(12):1625-1635.
Score: 0.009
-
Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group. J Clin Oncol. 2017 Oct 20; 35(30):3465-3473.
Score: 0.009
-
Hepatic Hilar Lymph Node Reactivity at Kasai Portoenterostomy for Biliary Atresia: Correlations With Age, Outcome, and Histology of Proximal Biliary Remnant. Pediatr Dev Pathol. 2018 Jan-Feb; 21(1):29-40.
Score: 0.008
-
Wilson disease: histopathological correlations with treatment on follow-up liver biopsies. World J Gastroenterol. 2010 Mar 28; 16(12):1487-94.
Score: 0.005
-
Diagnostic and therapeutic role of endoscopic retrograde cholangiopancreatography in biliary rhabdomyosarcoma. World J Gastroenterol. 2008 Aug 14; 14(30):4823-5.
Score: 0.005
-
Giant hepatic adenoma with atypical features in a patient on oxcarbazepine therapy. J Pediatr Surg. 2008 Apr; 43(4):751-4.
Score: 0.005
-
Successful management of rhabdoid tumor of the liver. J Pediatr Hematol Oncol. 2007 Jun; 29(6):406-8.
Score: 0.004
-
Fibrolamellar hepatocellular carcinoma in children and adolescents. Cancer. 2003 Apr 15; 97(8):2006-12.
Score: 0.003
-
Outcome of early hepatic portoenterostomy for biliary atresia. J Pediatr Gastroenterol Nutr. 2001 Mar; 32(3):265-9.
Score: 0.003
-
Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol. 2000 Jul; 18(14):2665-75.
Score: 0.003
-
Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest. 1997 Nov 05; 112(5):1332-7.
Score: 0.002
-
Chemotherapy can convert unresectable hepatoblastoma. J Pediatr Surg. 1992 Aug; 27(8):1080-3; discussion 1083-4.
Score: 0.002